These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 24473443)

  • 1. Plasma fibrinogen: now also an antidepressant response marker?
    Martins-de-Souza D; Maccarrone G; Ising M; Kloiber S; Lucae S; Holsboer F; Turck CW
    Transl Psychiatry; 2014 Jan; 4(1):e352. PubMed ID: 24473443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral blood and neuropsychological markers for the onset of action of antidepressant drugs in patients with Major Depressive Disorder.
    Tadić A; Wagner S; Gorbulev S; Dahmen N; Hiemke C; Braus DF; Lieb K
    BMC Psychiatry; 2011 Jan; 11():16. PubMed ID: 21269443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort.
    Lam RW; Milev R; Rotzinger S; Andreazza AC; Blier P; Brenner C; Daskalakis ZJ; Dharsee M; Downar J; Evans KR; Farzan F; Foster JA; Frey BN; Geraci J; Giacobbe P; Feilotter HE; Hall GB; Harkness KL; Hassel S; Ismail Z; Leri F; Liotti M; MacQueen GM; McAndrews MP; Minuzzi L; Müller DJ; Parikh SV; Placenza FM; Quilty LC; Ravindran AV; Salomons TV; Soares CN; Strother SC; Turecki G; Vaccarino AL; Vila-Rodriguez F; Kennedy SH;
    BMC Psychiatry; 2016 Apr; 16():105. PubMed ID: 27084692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics profiling reveals inflammatory biomarkers of antidepressant treatment response: Findings from the CO-MED trial.
    Gadad BS; Jha MK; Grannemann BD; Mayes TL; Trivedi MH
    J Psychiatr Res; 2017 Nov; 94():1-6. PubMed ID: 28628884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Machine Learning Analysis of Blood microRNA Data in Major Depression: A Case-Control Study for Biomarker Discovery.
    Qi B; Fiori LM; Turecki G; Trakadis YJ
    Int J Neuropsychopharmacol; 2020 Nov; 23(8):505-510. PubMed ID: 32365192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory biomarkers as differential predictors of antidepressant response.
    Hashimoto K
    Int J Mol Sci; 2015 Apr; 16(4):7796-801. PubMed ID: 25856677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of miR-1202, miR-135a, and miR-16 in Major Depressive Disorder and Antidepressant Response.
    Fiori LM; Lopez JP; Richard-Devantoy S; Berlim M; Chachamovich E; Jollant F; Foster J; Rotzinger S; Kennedy SH; Turecki G
    Int J Neuropsychopharmacol; 2017 Aug; 20(8):619-623. PubMed ID: 28520926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change in cytokine levels is not associated with rapid antidepressant response to ketamine in treatment-resistant depression.
    Park M; Newman LE; Gold PW; Luckenbaugh DA; Yuan P; Machado-Vieira R; Zarate CA
    J Psychiatr Res; 2017 Jan; 84():113-118. PubMed ID: 27718369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage-Derived Chemokine: A Putative Marker of Pharmacological Therapy Response in Major Depression?
    Milenkovic VM; Sarubin N; Hilbert S; Baghai TC; Stöffler F; Lima-Ojeda JM; Manook A; Almeqbaali K; Wetzel CH; Rupprecht R; Nothdurfter C
    Neuroimmunomodulation; 2017; 24(2):106-112. PubMed ID: 28898872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A longitudinal functional neuroimaging study in medication-naïve depression after antidepressant treatment.
    Tomioka H; Yamagata B; Kawasaki S; Pu S; Iwanami A; Hirano J; Nakagome K; Mimura M
    PLoS One; 2015; 10(3):e0120828. PubMed ID: 25786240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized proof of concept trial of GLYX-13, an N-methyl-D-aspartate receptor glycine site partial agonist, in major depressive disorder nonresponsive to a previous antidepressant agent.
    Preskorn S; Macaluso M; Mehra DO; Zammit G; Moskal JR; Burch RM;
    J Psychiatr Pract; 2015 Mar; 21(2):140-9. PubMed ID: 25782764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood plasma/IgG N-glycome biosignatures associated with major depressive disorder symptom severity and the antidepressant response.
    Park DI; Štambuk J; Razdorov G; Pučić-Baković M; Martins-de-Souza D; Lauc G; Turck CW
    Sci Rep; 2018 Jan; 8(1):179. PubMed ID: 29317657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal Hippocampal Subfields May Be Potential Predictors of Worse Early Response to Antidepressant Treatment in Drug-Naïve Patients With Major Depressive Disorder.
    Hu X; Zhang L; Hu X; Lu L; Tang S; Li H; Bu X; Gong Q; Huang X
    J Magn Reson Imaging; 2019 Jun; 49(6):1760-1768. PubMed ID: 30295348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of antidepressant treatment on peripheral inflammation markers - A meta-analysis.
    Więdłocha M; Marcinowicz P; Krupa R; Janoska-Jaździk M; Janus M; Dębowska W; Mosiołek A; Waszkiewicz N; Szulc A
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt C):217-226. PubMed ID: 28445690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of peripheral neurotrophin levels for the diagnosis of depression and response to treatment: A systematic review and meta-analysis.
    Shi Y; Luan D; Song R; Zhang Z
    Eur Neuropsychopharmacol; 2020 Dec; 41():40-51. PubMed ID: 32980240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological profiling of prospective antidepressant response in major depressive disorder: Associations with (neuro)inflammation, fatty acid metabolism, and amygdala-reactivity.
    Mocking RJT; Nap TS; Westerink AM; Assies J; Vaz FM; Koeter MWJ; Ruhé HG; Schene AH
    Psychoneuroendocrinology; 2017 May; 79():84-92. PubMed ID: 28262603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood-based biomarkers in depression: emerging themes in clinical research.
    Uddin M
    Mol Diagn Ther; 2014 Oct; 18(5):469-82. PubMed ID: 24923456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suicidal ideation and other persisting symptoms after CBT or antidepressant medication treatment for major depressive disorder.
    Dunlop BW; Polychroniou PE; Rakofsky JJ; Nemeroff CB; Craighead WE; Mayberg HS
    Psychol Med; 2019 Aug; 49(11):1869-1878. PubMed ID: 30207254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart rate variability as a biomarker of anxious depression response to antidepressant medication.
    Kircanski K; Williams LM; Gotlib IH
    Depress Anxiety; 2019 Jan; 36(1):63-71. PubMed ID: 30311742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral cytokine levels and response to antidepressant treatment in depression: a systematic review and meta-analysis.
    Liu JJ; Wei YB; Strawbridge R; Bao Y; Chang S; Shi L; Que J; Gadad BS; Trivedi MH; Kelsoe JR; Lu L
    Mol Psychiatry; 2020 Feb; 25(2):339-350. PubMed ID: 31427752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.